Health literacy needs support, now more than everThe COVID-19 pandemic has brought healthcare guidelines and scientific advances front-of-mind on a global scale, in the process Share XHealth literacy needs support, now more than everhttps://pharmaphorum.com/views-analysis-patients/health-literacy-needs-support-now-more-than-ever/
Education and empowerment would provide more equal access to careElla Balasa says she owes her life to the experimental phage therapy she was able access in no Share XEducation and empowerment would provide more equal access to carehttps://pharmaphorum.com/views-analysis-patients/education-and-empowerment-would-provide-more-equal-access-to-care/
Unlocking the potential in rare disease research with decentralised trialsA survey by rare disease patient network Raremark found that 86% of the community members asked were interested Share XUnlocking the potential in rare disease research with decentralised trialshttps://pharmaphorum.com/views-analysis-patients/unlocking-the-potential-in-rare-disease-research-with-decentralised-trials/
A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
Enabling new models of care: pursuing pharma’s partnership potentialThere is a huge, ongoing shift in how health and wellness is approached in the UK, and the Share XEnabling new models of care: pursuing pharma’s partnership potentialhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/enabling-new-models-of-care-pursuing-pharmas-partnership-potential/
‘No going back’ for clinical trials after COVIDTrial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as Share X‘No going back’ for clinical trials after COVIDhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/no-going-back-for-clinical-trials-after-covid/
How patient insights are changing trial solutionsPatients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening. That’s Share XHow patient insights are changing trial solutionshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/how-patient-insights-are-changing-trial-solutions/
True patient-focused research through decentralised and hybrid trialsHow can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector Share XTrue patient-focused research through decentralised and hybrid trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/true-patient-focused-research-through-decentralised-and-hybrid-trials/
Boosting the impact of patient servicesNew research from Accenture has revealed that adoption of patient support services hasn’t improved since 2015 despite increasing Share XBoosting the impact of patient serviceshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/boosting-impact-patient-services/
